BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16687660)

  • 1. Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells.
    Lee-Rueckert M; Vikstedt R; Metso J; Ehnholm C; Kovanen PT; Jauhiainen M
    J Lipid Res; 2006 Aug; 47(8):1725-32. PubMed ID: 16687660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles.
    Vikstedt R; Metso J; Hakala J; Olkkonen VM; Ehnholm C; Jauhiainen M
    Biochemistry; 2007 Oct; 46(42):11979-86. PubMed ID: 17900150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells.
    Oram JF; Wolfbauer G; Vaughan AM; Tang C; Albers JJ
    J Biol Chem; 2003 Dec; 278(52):52379-85. PubMed ID: 14559902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.
    Yvan-Charvet L; Ranalletta M; Wang N; Han S; Terasaka N; Li R; Welch C; Tall AR
    J Clin Invest; 2007 Dec; 117(12):3900-8. PubMed ID: 17992262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of apolipoprotein A-I on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells.
    Tang CK; Tang GH; Yi GH; Wang Z; Liu LS; Wan S; Yuan ZH; He XS; Yang JH; Ruan CG; Yang YZ
    Acta Biochim Biophys Sin (Shanghai); 2004 Mar; 36(3):218-26. PubMed ID: 15202507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling.
    Ji A; Wroblewski JM; Webb NR; van der Westhuyzen DR
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1910-6. PubMed ID: 25060793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.
    Kuwano T; Bi X; Cipollari E; Yasuda T; Lagor WR; Szapary HJ; Tohyama J; Millar JS; Billheimer JT; Lyssenko NN; Rader DJ
    J Lipid Res; 2017 Apr; 58(4):731-741. PubMed ID: 28137768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte phospholipid transfer protein and lipoprotein metabolism.
    Jiang H; Yazdanyar A; Lou B; Chen Y; Zhao X; Li R; Hoang Bui H; Kuo MS; Navab M; Qin S; Li Z; Jin W; Jiang XC
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):316-22. PubMed ID: 25477345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
    Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
    Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation.
    Zhang M; Li L; Xie W; Wu JF; Yao F; Tan YL; Xia XD; Liu XY; Liu D; Lan G; Zeng MY; Gong D; Cheng HP; Huang C; Zhao ZW; Zheng XL; Tang CK
    Atherosclerosis; 2016 May; 248():149-59. PubMed ID: 27017521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
    Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
    Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
    PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidic extracellular environments strongly impair ABCA1-mediated cholesterol efflux from human macrophage foam cells.
    Lee-Rueckert M; Lappalainen J; Leinonen H; Pihlajamaa T; Jauhiainen M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1766-72. PubMed ID: 20702810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
    Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
    J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity.
    Nakanishi S; Vikstedt R; Söderlund S; Lee-Rueckert M; Hiukka A; Ehnholm C; Muilu M; Metso J; Naukkarinen J; Palotie L; Kovanen PT; Jauhiainen M; Taskinen MR
    J Lipid Res; 2009 Feb; 50(2):183-92. PubMed ID: 18787236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of phospholipid transfer protein (PLTP) and PLTP-generated pre-beta-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells.
    Lee M; Metso J; Jauhiainen M; Kovanen PT
    J Biol Chem; 2003 Apr; 278(15):13539-45. PubMed ID: 12531890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
    Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI
    J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells.
    Bielicki JK; McCall MR; Forte TM
    J Lipid Res; 1999 Jan; 40(1):85-92. PubMed ID: 9869653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors.
    Son SH; Goo YH; Choi M; Saha PK; Oka K; Chan LC; Paul A
    Cardiovasc Res; 2016 Feb; 109(2):294-304. PubMed ID: 26487692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.